AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8922326 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 36
Study 1391258 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorothiazide (diuretic therapy)
Number of subjects: 17
Study 1391258 — intervention group
Group type: COMPARATOR
Intervention: Control (no diuretics)
Number of subjects: 17
Study 29448460 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical analysis of stress serrations and acoustic emission in AlMgScZr alloy
Number of subjects: 0
Study 27583530 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethicon Silk® 4/0
Number of subjects: 30
Study 27583530 — intervention group
Group type: EXPERIMENTAL
Intervention: B. Braun Dafilon® 4/0
Number of subjects: 30
Study 27583530 — intervention group
Group type: EXPERIMENTAL
Intervention: B. Braun Safil® 4/0
Number of subjects: 30
Study 25360036 — intervention group
Group type: EXPERIMENTAL
Intervention: Geboes score (GS)
Number of subjects: 49
Study 25360036 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Riley score (MRS)
Number of subjects: 49
Study 25360036 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual analogue scale (VAS)
Number of subjects: 49
Study 25360036 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between GS and VAS
Number of subjects: 49
Study 25360036 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between MRS and VAS
Number of subjects: 49
Study 23002698 — intervention group
Group type: EXPERIMENTAL
Intervention: Social interaction task
Number of subjects: 82
Study 23002698 — intervention group
Group type: COMPARATOR
Intervention: Reading task
Number of subjects: 82
Study 21182781 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg intravenous dexamethasone
Number of subjects: 70
Study 21182781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 19339559 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated perioperative care and rehabilitation protocol
Number of subjects: 87
Study 19339559 — intervention group
Group type: COMPARATOR
Intervention: Standard protocol
Number of subjects: 87
Study 16762982 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg pioglitazone once daily for 4 weeks
Number of subjects: 16
Study 16762982 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion of TNF-alpha (10 ng/100 mL forearm volume/min for 2 h)
Number of subjects: 16
Study 16762982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 15217043 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact of Event Scale (IES)
Number of subjects: 37
Study 15217043 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Support and Emotional Expressiveness
Number of subjects: 37
Study 11375879 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilisation training combined with dynamic-static resistance training (group 3)
Number of subjects: 59
Study 11375879 — intervention group
Group type: COMPARATOR
Intervention: Stabilisation training (group 1)
Number of subjects: 59
Study 11375879 — intervention group
Group type: COMPARATOR
Intervention: Stabilisation training combined with dynamic resistance training (group 2)
Number of subjects: 59
Study 8985221 — intervention group
Group type: EXPERIMENTAL
Intervention: Meningococcal polysaccharide vaccine
Number of subjects: 221
Study 8985221 — intervention group
Group type: COMPARATOR
Intervention: Polysaccharide vaccine
Number of subjects: 221
Study 8985221 — intervention group
Group type: COMPARATOR
Intervention: Conjugate vaccine
Number of subjects: 221
Study 8115726 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfluoropropane gas
Number of subjects: 340
Study 8115726 — intervention group
Group type: COMPARATOR
Intervention: Silicone oil
Number of subjects: 340
Study 8115726 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (no prior vitrectomy)
Number of subjects: 340
Study 8115726 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (prior vitrectomy)
Number of subjects: 340
Study 8115726 — intervention group
Group type: EXPERIMENTAL
Intervention: More than one operation
Number of subjects: 340
Study 2892254 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine 30 mg
Number of subjects: 8
Study 2892254 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine 100 mg
Number of subjects: 8
Study 2892254 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine 300 mg
Number of subjects: 8
Study 2892254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 2892254 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 8
Study 29273494 — intervention group
Group type: EXPERIMENTAL
Intervention: Gow-Gates nerve block (GGNB)
Number of subjects: 150
Study 29273494 — intervention group
Group type: EXPERIMENTAL
Intervention: Inferior alveolar nerve block (IANB)
Number of subjects: 150
Study 29273494 — intervention group
Group type: EXPERIMENTAL
Intervention: Gow-Gates nerve block (GGNB) + Inferior alveolar nerve block (IANB)
Number of subjects: 150
Study 27642053 — intervention group
Group type: EXPERIMENTAL
Intervention: Team training programme focused on crew resource management and checklist utilization in 16 intervention hospitals.
Number of subjects: 22779
Study 27642053 — intervention group
Group type: COMPARATOR
Intervention: Control hospitals (15 hospitals) without the team training programme.
Number of subjects: 22779
Study 27642053 — intervention group
Group type: COMPARATOR
Intervention: Comparison of surgical outcomes between intervention and control hospitals.
Number of subjects: 22779
Study 24045086 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 30
Study 24045086 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 22395850 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous stochastic resonance whole body vibration (SR‐WBV)
Number of subjects: 50
Study 22395850 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent stochastic resonance whole body vibration (SR‐WBV)
Number of subjects: 50
Study 20524910 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium bromide 18 µg once daily
Number of subjects: 5992
Study 20524910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5992
Study 18519003 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse and GP partnership care based on Australian COPDX guidelines
Number of subjects: 0
Study 18519003 — intervention group
Group type: COMPARATOR
Intervention: Usual care from GPs
Number of subjects: 0
Study 18519003 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse and GP partnership care
Number of subjects: 0
Study 16009987 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee laxity
Number of subjects: 36
Study 16009987 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioception
Number of subjects: 36
Study 16009987 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle strength
Number of subjects: 36
Study 16009987 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilometry (amplitude and average speed of center of pressure movements)
Number of subjects: 36
Study 16009987 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective estimation of extremity function (measured on a visual analog scale)
Number of subjects: 36
Study 13678868 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (titrated to 32 mg once daily)
Number of subjects: 7601
Study 13678868 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7601
Study 10543583 — intervention group
Group type: EXPERIMENTAL
Intervention: Megadose Vitamin C (1000 mg hourly for the first 6 hours, then 3 times daily thereafter)
Number of subjects: 715
Study 10543583 — intervention group
Group type: COMPARATOR
Intervention: Control group (pain relievers and decongestants)
Number of subjects: 715
Study 8903809 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg ketorolac
Number of subjects: 47
Study 8903809 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg meperidine
Number of subjects: 47
Study 8903809 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution (control)
Number of subjects: 47
Study 2070311 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-virion vaccine (SVV)
Number of subjects: 358
Study 2070311 — intervention group
Group type: COMPARATOR
Intervention: Whole-virion vaccine (WVV)
Number of subjects: 358
Study 2070311 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SVV and WVV
Number of subjects: 358
Study 6354056 — intervention group
Group type: EXPERIMENTAL
Intervention: Opsite
Number of subjects: 50
Study 6354056 — intervention group
Group type: COMPARATOR
Intervention: Sofratulle
Number of subjects: 50
Study 31524141 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided injection (n=23)
Number of subjects: 47
Study 31524141 — intervention group
Group type: COMPARATOR
Intervention: Blind injection (n=24)
Number of subjects: 47
Study 31524141 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study 30638985 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg/day)
Number of subjects: 95
Study 30638985 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 30638985 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone vs Placebo
Number of subjects: 95
Study 28853992 — intervention group
Group type: EXPERIMENTAL
Intervention: Cookies containing 6% bay leaf powder (B6)
Number of subjects: 20
Study 28853992 — intervention group
Group type: COMPARATOR
Intervention: Control cookies (CC)
Number of subjects: 20
Study 28853992 — intervention group
Group type: EXPERIMENTAL
Intervention: Cookies containing 3% bay leaf powder (B3)
Number of subjects: 20
Study 26376447 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (10 mg, single dose)
Number of subjects: 10
Study 26376447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 23711703 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisinin combination therapy (ACT) AS+SP
Number of subjects: 207
Study 23711703 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisinin combination therapy (ACT) AM+LF
Number of subjects: 207
Study 21194892 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0-mm locking plates (group A)
Number of subjects: 50
Study 21194892 — intervention group
Group type: COMPARATOR
Intervention: 2.0-mm nonlocking plates (group B)
Number of subjects: 50
Study 19122552 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spinal and epidural anaesthesia (CSEA)
Number of subjects: 70
Study 19122552 — intervention group
Group type: COMPARATOR
Intervention: Single shot spinal anaesthesia (SSSA)
Number of subjects: 70
Study 17582033 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest Pain Unit (CPU) care
Number of subjects: 1644
Study 17582033 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised protocols for biochemical cardiac marker and exercise treadmill testing
Number of subjects: 1644
Study 12872150 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-α (IFN) treatment
Number of subjects: 163
Study 12872150 — intervention group
Group type: COMPARATOR
Intervention: No IFN treatment (Control)
Number of subjects: 163
Study 11091498 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (arm A)
Number of subjects: 60
Study 11091498 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF (arm B)
Number of subjects: 60
Study 11091498 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF/G-CSF (arm C)
Number of subjects: 60
Study 11091498 — intervention group
Group type: EXPERIMENTAL
Intervention: All arms
Number of subjects: 60
Study 9350159 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular dexamethasone (IMD)
Number of subjects: 42
Study 9350159 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisone (OP)
Number of subjects: 42
Study 8477212 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime and gentamicin
Number of subjects: 40
Study 8477212 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin and gentamicin
Number of subjects: 40
Study 3454368 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine (PE) 2.5% and tropicamide 1.0% (Group A)
Number of subjects: 34
Study 3454368 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine (PE) 2.5%, tropicamide 0.5%, and cyclopentolate 0.5% (Group B)
Number of subjects: 34
Study 3454368 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine (PE) 1.0% and tropicamide 1.0% (Group C)
Number of subjects: 34
Study 3454368 — intervention group
Group type: COMPARATOR
Intervention: Saline 0.9% (Group D)
Number of subjects: 34
Study 31865628 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis (300-μg/kg delta-9-tetrahydrocannabinol)
Number of subjects: 24
Study 31865628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 30220290 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisymptom tablet (containing paracetamol, pseudoephedrine hydrochloride, dextromethorphan hydrobromide, and chlorpheniramine maleate)
Number of subjects: 53
Study 30220290 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet
Number of subjects: 53
Study 30220290 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisymptom tablet
Number of subjects: 53
Study 27941973 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous furosemide (125-250mg/bid) plus hypertonic saline solution (HSS)
Number of subjects: 59
Study 27941973 — intervention group
Group type: COMPARATOR
Intervention: Repeated paracentesis
Number of subjects: 59
Study 24888857 — intervention group
Group type: EXPERIMENTAL
Intervention: MBP+oral antibiotics
Number of subjects: 5473
Study 24888857 — intervention group
Group type: COMPARATOR
Intervention: MBP alone
Number of subjects: 5473
Study 24888857 — intervention group
Group type: COMPARATOR
Intervention: Oral antibiotics alone
Number of subjects: 5473
Study 24888857 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall evidence-based preparation
Number of subjects: 5473
Study 22226313 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic medicines
Number of subjects: 28
Study 22226313 — intervention group
Group type: COMPARATOR
Intervention: Placebo homeopathy
Number of subjects: 28
Study 20307657 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdose (100 microg) of (14)C-drug administered orally
Number of subjects: 6
Study 20307657 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic dose (120mg) of fexofenadine administered orally
Number of subjects: 6
Study 20307657 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdose (100 microg) of (14)C-drug administered intravenously
Number of subjects: 6
Study 20307657 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic dose (120mg) of fexofenadine administered with intravenous tracer dose (100 microg) of (14)C-drug
Number of subjects: 6
Study 18593715 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 1295
Study 15816442 — intervention group
Group type: EXPERIMENTAL
Intervention: Total mesorectal excision (TME) with adjuvant systemic chemotherapy and radiotherapy
Number of subjects: 210
Study 15816442 — intervention group
Group type: COMPARATOR
Intervention: Total mesorectal excision (TME) with adjuvant stop-flow perfusion along with systemic chemotherapy
Number of subjects: 210
Study 12177032 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-impregnated bednets
Number of subjects: 0
Study 10947491 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltitrexed
Number of subjects: 495
Study 10947491 — intervention group
Group type: COMPARATOR
Intervention: 5FU + FA
Number of subjects: 495
Study 8891515 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate, intermittent exercise (two 30-min bouts at approximately 50% VO2peak)
Number of subjects: 11
Study 8891515 — intervention group
Group type: COMPARATOR
Intervention: Heat exposure (40 degrees C, 30% relative humidity)
Number of subjects: 11
Study 8891515 — intervention group
Group type: COMPARATOR
Intervention: Seated control (3 hours)
Number of subjects: 11
Study 1747959 — intervention group
Group type: EXPERIMENTAL
Intervention: lymphoblastoid interferon (lyIFN)
Number of subjects: 599
Study 7044387 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of pirenzepine
Number of subjects: 6
Study 7044387 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of pirenzepine
Number of subjects: 6
Study 31394990 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific loss framing
Number of subjects: 401
Study 31394990 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific gain framing
Number of subjects: 401
Study 31394990 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonspecific loss framing
Number of subjects: 401
Study 31394990 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonspecific gain framing
Number of subjects: 401
Study 30703847 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% BFR
Number of subjects: 24
Study 30703847 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% BFR
Number of subjects: 24
Study 30703847 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% BFR
Number of subjects: 24
Study 30703847 — intervention group
Group type: EXPERIMENTAL
Intervention: All BFR levels
Number of subjects: 24
Study 27778483 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern scanning laser trabeculoplasty (PSLT)
Number of subjects: 29
Study 27778483 — intervention group
Group type: COMPARATOR
Intervention: Selective laser trabeculoplasty (SLT)
Number of subjects: 29
Study 25847941 — intervention group
Group type: EXPERIMENTAL
Intervention: Glembatumumab vedotin (n = 83)
Number of subjects: 124
Study 25847941 — intervention group
Group type: COMPARATOR
Intervention: Investigator's choice (IC) chemotherapy (n = 41)
Number of subjects: 124
Study 25847941 — intervention group
Group type: EXPERIMENTAL
Intervention: Glembatumumab vedotin (n = 23 with gpNMB overexpression)
Number of subjects: 124
Study 25847941 — intervention group
Group type: COMPARATOR
Intervention: Investigator's choice (IC) chemotherapy (n = 11 with gpNMB overexpression)
Number of subjects: 124
Study 25847941 — intervention group
Group type: EXPERIMENTAL
Intervention: Glembatumumab vedotin (n = 28 with TNBC)
Number of subjects: 124
Study 25847941 — intervention group
Group type: COMPARATOR
Intervention: Investigator's choice (IC) chemotherapy (n = 11 with TNBC)
Number of subjects: 124
Study 25847941 — intervention group
Group type: EXPERIMENTAL
Intervention: Glembatumumab vedotin (n = 10 with gpNMB-overexpressing TNBC)
Number of subjects: 124
Study 25847941 — intervention group
Group type: COMPARATOR
Intervention: Investigator's choice (IC) chemotherapy (n = 6 with gpNMB-overexpressing TNBC)
Number of subjects: 124
Study 24905305 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin-E along with regular medicines
Number of subjects: 92
Study 24905305 — intervention group
Group type: COMPARATOR
Intervention: Usual care (pregabalin with oral hypoglycemic agents)
Number of subjects: 92
Study 22822075 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium acetate, lanthanum carbonate, sevelamer carbonate (active therapy)
Number of subjects: 148
Study 22822075 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 148
Study 20815769 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 7
Study 18198804 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard interventions (mask optimization, heated humidification, topical nasal therapy, sleep apnea education)
Number of subjects: 204
Study 18198804 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible bilevel positive airway pressure
Number of subjects: 204
Study 18198804 — intervention group
Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 204
Study 16310576 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein (30 grams daily for 12 weeks)
Number of subjects: 37
Study 16310576 — intervention group
Group type: COMPARATOR
Intervention: Milk protein (control group)
Number of subjects: 37
Study 16310576 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable (normolipidemic subjects)
Number of subjects: 37
Study 12033980 — intervention group
Group type: EXPERIMENTAL
Intervention: High Dk Balafilcon A silicone hydrogel lens
Number of subjects: 24
Study 12033980 — intervention group
Group type: COMPARATOR
Intervention: Low Dk HEMA lens
Number of subjects: 24
Study 9829029 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour therapy (BT) plus fluvoxamine (maximum dosage 300 mg, mean dose 288.1 mg)
Number of subjects: 30
Study 9829029 — intervention group
Group type: COMPARATOR
Intervention: Behaviour therapy (BT) plus placebo
Number of subjects: 30
Study 7663004 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients without microalbuminuria
Number of subjects: 50
Study 7663004 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients with microalbuminuria
Number of subjects: 50
Study 7663004 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 50
Study 7663004 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 50
Study 2718706 — intervention group
Group type: EXPERIMENTAL
Intervention: halothane (H)
Number of subjects: 23
Study 2718706 — intervention group
Group type: EXPERIMENTAL
Intervention: enflurane (E)
Number of subjects: 23
Study 2718706 — intervention group
Group type: EXPERIMENTAL
Intervention: isoflurane (I)
Number of subjects: 23
Study 2718706 — intervention group
Group type: EXPERIMENTAL
Intervention: labetalol
Number of subjects: 23
Study 7372251 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 51
Study 7372251 — intervention group
Group type: COMPARATOR
Intervention: Chlordiazepoxide
Number of subjects: 51
Study 7372251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 31285228 — intervention group
Group type: EXPERIMENTAL
Intervention: Filociclovir (100 mg, 350 mg, or 750 mg daily for 7 days)
Number of subjects: 24
Study 31285228 — intervention group
Group type: EXPERIMENTAL
Intervention: Filociclovir (750 mg)
Number of subjects: 24
Study 31285228 — intervention group
Group type: EXPERIMENTAL
Intervention: Filociclovir (100 mg, 350 mg, or 750 mg)
Number of subjects: 24
Study 31285228 — intervention group
Group type: EXPERIMENTAL
Intervention: Filociclovir (350 mg)
Number of subjects: 24
Study 31285228 — intervention group
Group type: EXPERIMENTAL
Intervention: Filociclovir
Number of subjects: 24
Study 31285228 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 28138867 — intervention group
Group type: EXPERIMENTAL
Intervention: Relational active music therapy treatments
Number of subjects: 38